Follow the PRIM, S.A. stock price and the full management transaction log of the company, a listed equity based in Spain. Shares are quoted on ES ES, under the supervision of CNMV. Operating in the Health Care sector, PRIM, S.A. has logged 0 insider filings. Market capitalisation: €4.7bn. Every trade is openly available.
Analysts rate PRIM, S.A. Buy (bullish), based on 14 analysts. Average price target: US$127.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
PRIM, S.A. is a company listed on the XMAD market, specializing in the healthcare and pharmaceutical sector. It focuses on the development and distribution of pharmaceutical products and health solutions.